Interleukin-10 level is associated with post-stroke depression in acute ischaemic stroke patients DOI

Chu‐huai Chi,

Yuanyuan Huang,

Suzhen Ye

et al.

Journal of Affective Disorders, Journal Year: 2021, Volume and Issue: 293, P. 254 - 260

Published: June 25, 2021

Language: Английский

Resilience and immunity DOI Creative Commons
Robert Dantzer, Sheldon Cohen, Scott J. Russo

et al.

Brain Behavior and Immunity, Journal Year: 2018, Volume and Issue: 74, P. 28 - 42

Published: Aug. 10, 2018

Resilience is the process that allows individuals to adapt adverse conditions and recover from them. This favored by individual qualities have been amply studied in field of stress such as personal control, positive affect, optimism, social support. Biopsychosocial studies on promote resilience show these factors help protect against deleterious influences stressors physiology general immunity particular. The reverse also true there evidence immune processes influence resilience. Most data supporting this relationship comes animal differences ability resist situations chronic stress. These build knowledge has accumulated brain behavior both human studies. In general, resilient a different immunophenotype susceptible individuals. It possible render vice versa changing their inflammatory phenotype. adaptive phenotype inflammation-induced symptoms. modulation bidirectional relationships between gut microbiota opens possibility them probiotics prebiotics. However, more focused reciprocal will be necessary before can put into practice.

Language: Английский

Citations

266

Immune targets for therapeutic development in depression: towards precision medicine DOI Creative Commons
Wayne C. Drevets, Gayle Wittenberg, Edward T. Bullmore

et al.

Nature Reviews Drug Discovery, Journal Year: 2022, Volume and Issue: 21(3), P. 224 - 244

Published: Jan. 17, 2022

Over the past two decades, compelling evidence has emerged indicating that immune mechanisms can contribute to pathogenesis of major depressive disorder (MDD) and drugs with primary targets improve symptoms. Patients MDD are heterogeneous respect symptoms, treatment responses biological correlates. Defining a narrower patient group based on biology could increase response rates in certain subgroups: advance clinical psychiatry. For example, patients elevated pro-inflammatory biomarkers less likely respond conventional antidepressant drugs, but novel immune-based therapeutics potentially address their unmet needs. This article outlines framework for developing targeting subtype within reviews current state neuroimmune drug development mood disorders. We discuss causal role depression, together under investigation randomized controlled trials, biomarker elucidating link neural mechanisms, phenotypic selection strategies, need among MDD.

Language: Английский

Citations

210

Isoliquiritin ameliorates depression by suppressing NLRP3-mediated pyroptosis via miRNA-27a/SYK/NF-κB axis DOI Creative Commons
Yuanjie Li,

Wen Song,

Yue Tong

et al.

Journal of Neuroinflammation, Journal Year: 2021, Volume and Issue: 18(1)

Published: Jan. 5, 2021

Abstract Background The NLRP3-mediated pyroptosis, which could be regulated by miRNA-27a, is a key player in the development of depression. Isoliquiritin phenolic flavonoid compound that has been demonstrated to suppress pyroptosis. However, it still unknown whether isoliquiritin confer antidepressant activity via decreasing pyroptosis stimulating miRNA-27a. Thus, current study, we explored and its underlying mechanism. Methods Expression miRNA-27a depressed patients or mice was measured using qRT-PCR. Luciferase reporter assay performed illustrate link between SYK. Lipopolysaccharide (LPS) chronic social defeat stress (CSDS) depression models were established investigate actions isoliquiritin. Changes miRNA-27a/SYK/NF-κB axis also examined. role isoliquiritin-related effect further investigated inhibitors mimics Results Our results showed expression downregulated serum patients, decreased hippocampus observed rodent SYK gene significantly reduced mimic incubation. profoundly attenuated LPS CSDS-induced depressive symptoms, as well anxiety behavior. In hippocampus, CSDS mRNA expression; increased protein levels SYK, p-NF-κB, NLRP3: cleaved Caspase-1, IL-1β, GSDMD-N: elevated concentration IL-6, TNF-α, all restored administration. Meanwhile, upregulated hippocampal NeuN level, improved survival morphology neurons, pyroptosis-related neuronal cell death. Moreover, protected primary microglia against adenosine triphosphate (ATP) elicited NLRP3 inflammasome activation vitro, evidenced declined NLRP3; GSDMD-N; Nevertheless, reversed isoliquiritin-generated therapeutic efficacy vitro. Furthermore, cytoprotective similar ATP-treated microglia. Taken together, these findings suggest possesses potent property, requires controlled decrease cascade.

Language: Английский

Citations

202

T-Cell Mediated Inflammation in Postmenopausal Osteoporosis DOI Creative Commons
Di Wu,

Anna Cline-Smith,

Elena V. Shashkova

et al.

Frontiers in Immunology, Journal Year: 2021, Volume and Issue: 12

Published: June 30, 2021

Osteoporosis is the most prevalent metabolic bone disease that affects half women in sixth and seventh decade of life. characterized by uncoupled resorption leads to low mass, compromised microarchitecture structural deterioration increases likelihood fracture with minimal trauma, known as fragility fractures. Several factors contribute osteoporosis men women. In women, menopause – cessation ovarian function, one leading causes primary osteoporosis. Over past three decades there has been growing appreciation adaptive immune system plays a fundamental role development postmenopausal osteoporosis, both humans mouse models. this review, we highlight recent data on interactions between T cells skeletal context Finally, review studies interventions ameliorate

Language: Английский

Citations

144

Inflammation-Induced Tryptophan Breakdown is Related With Anemia, Fatigue, and Depression in Cancer DOI Creative Commons
Lukas Lanser,

Patricia Kink,

Eva Maria Egger

et al.

Frontiers in Immunology, Journal Year: 2020, Volume and Issue: 11

Published: Feb. 21, 2020

Many patients with cancer suffer from anemia, depression and an impaired quality of life (QoL). These often also show decreased plasma tryptophan levels increased kynurenine concentrations in parallel elevated Th1 type immune activation marker neopterin. In the course anti-tumor response, pro-inflammatory cytokine interferon gamma (IFN-𝛾) induces both, enzyme indoleamine 2,3-dioxygenase (IDO) to degrade GTP-cyclohydrolase I form High neopterin as well ratio (Kyn/Trp) blood are predictive for a worse outcome. Inflammation-mediated catabolism along pathway is related fatigue anemia QoL solid tumors. fact, enhanced breakdown might greatly contribute development patients. IDO stimulation exert regulatory mechanisms, which may impair responses. addition, tumor cells can weaken responses directed against them. expression tissue associated poor prognosis The efficiency IDO-inhibitors inhibit progression currently tested combination established chemotherapies checkpoint inhibitors. its possible influence on persistence discussed.

Language: Английский

Citations

142

Immunotherapy for depression: Recent insights and future targets DOI
Ying Bai, Yang Cai,

Di Chang

et al.

Pharmacology & Therapeutics, Journal Year: 2024, Volume and Issue: 257, P. 108624 - 108624

Published: March 3, 2024

Language: Английский

Citations

18

The immunological perspective of major depressive disorder: unveiling the interactions between central and peripheral immune mechanisms DOI Creative Commons
Jiao Wang, Jiayi Lin,

Yanfang Deng

et al.

Journal of Neuroinflammation, Journal Year: 2025, Volume and Issue: 22(1)

Published: Jan. 19, 2025

Major depressive disorder is a prevalent mental disorder, yet its pathogenesis remains poorly understood. Accumulating evidence implicates dysregulated immune mechanisms as key contributors to disorders. This review elucidates the complex interplay between peripheral and central components underlying pathology. Peripherally, systemic inflammation, gut dysregulation, dysfunction in organs including gut, liver, spleen adipose tissue influence brain function through neural molecular pathways. Within nervous system, aberrant microglial astrocytes activation, cytokine imbalances, compromised blood-brain barrier integrity propagate neuroinflammation, disrupting neurotransmission, impairing neuroplasticity, promoting neuronal injury. The crosstalk immunity creates vicious cycle exacerbating neuropathology. Unraveling these multifaceted immune-mediated provides insights into major disorder's pathogenic basis potential biomarkers targets. Modulating both responses represent promising multidimensional therapeutic strategy.

Language: Английский

Citations

5

T Cells as an Emerging Target for Chronic Pain Therapy DOI Creative Commons
Geoffroy Laumet, Jiacheng Ma, Alfred J. Robison

et al.

Frontiers in Molecular Neuroscience, Journal Year: 2019, Volume and Issue: 12

Published: Sept. 11, 2019

The immune system is critically involved in the development and maintenance of chronic pain. However, T cells, one main regulators response, have only recently become a focus investigations on pain pathophysiology. Emerging clinical data suggest that patients with different phenotypic profile circulating cells compared to controls. At preclinical level, findings function are mixed differ between nerve injury, chemotherapy, inflammatory models persistent Depending type subset sex animal, may contribute onset and/or resolution pain, underlining as major player transition from acute Specific cell subsets release mediators such cytokines endogenous opioid peptides can promote, suppress, or even resolve Inhibiting pain-promoting functions enhancing beneficial effects pro-resolution offer new disease-modifying strategies for treatment critical need view current crisis.

Language: Английский

Citations

91

Interleukin-10 resolves pain hypersensitivity induced by cisplatin by reversing sensory neuron hyperexcitability DOI
Geoffroy Laumet, Alexis Bavencoffe,

Jules D. Edralin

et al.

Pain, Journal Year: 2020, Volume and Issue: 161(10), P. 2344 - 2352

Published: May 13, 2020

Abstract Understanding the mechanisms that drive transition from acute to chronic pain is essential identify new therapeutic targets. The importance of endogenous resolution pathways acting as a “brake” prevent development has been largely ignored. We examined role interleukin-10 (IL-10) in neuropathic induced by cisplatin. In search an underlying mechanism, we studied effect cisplatin and IL-10 on spontaneous activity (SA) dorsal root ganglia neurons. Cisplatin (2 mg/kg daily for 3 days) mechanical hypersensitivity resolved within weeks. both sexes, was delayed Il10 −/− mice, WT mice treated intrathecally with neutralizing anti-IL-10 antibody, cell-targeted deletion IL-10R1 advillin-positive sensory Electrophysiologically, small- medium-sized neurons cisplatin-treated displayed increase incidence SA. treatment also depolarized resting membrane potential, decreased action potential voltage threshold rheobase, while increasing ongoing at −45 mV amplitude depolarizing fluctuations. vitro addition (10 ng/mL) reversed SA fluctuation amplitudes, but unexpectedly had little other electrophysiological parameters affected Collectively, our findings challenge prevailing concept resolves solely dampening neuroinflammation demonstrate model chemotherapy-induced prevents binding receptors regulate their activity.

Language: Английский

Citations

81

The cytokine network in the pathogenesis of major depressive disorder. Close to translation? DOI
Maria Cristina Petralia, Emanuela Mazzon, Paolo Fagone

et al.

Autoimmunity Reviews, Journal Year: 2020, Volume and Issue: 19(5), P. 102504 - 102504

Published: March 13, 2020

Language: Английский

Citations

76